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Abstract.
Background: Physical activity has the potential to improve physical function in patients with Alzheimer’s disease (AD) and
may contribute to modify disease processes and cognitive function.
Objective: The aim of this study was to investigate 1) the effect of moderate-high-intensity aerobic exercise on cardiorespi-
ratory fitness, i.e., peak oxygen uptake (VO2peak) determined by direct breath-by-breath cardiopulmonary exercise test, and
2) the association between changes in VO2peak and changes in cognition and neuropsychiatric symptoms in patients with
mild AD.
Methods: The study is based on secondary outcome analyses from the large single-blinded multi-center study ADEX
(Preserving Cognition, Quality of Life, Physical Health and Functional Ability in Alzheimer’s Disease: The Effect of Physical
Exercise). A preselected sub-group of 55 participants (age 52–83 years), 29 from the intervention group (IG) and 26 from
the control group (CG), was included. IG performed 16 weeks of supervised moderate-to-high intensity aerobic exercise.
Assessments of VO2peak, mental speed and attention (Symbol Digit Modalities Test, SDMT), and neuropsychiatric symptoms
(Neuropsychiatric Inventory, NPI) were performed at baseline and at 16 weeks.
Result: VO2peak increased 13% in the IG and a between-group difference in mean change (3.92 ml/kg/min, 95% CI 6.34–1.51,
p = 0.003) was present in favor of the IG. Combined data from IG and CG showed positive associations between changes in
VO2peak and changes in NPI (Rho = –0.41, p = 0.042) and changes in SDMT (Rho = 0.36, p = 0.010), respectively.
Conclusion: Aerobic exercise improves VO2peak in community-dwelling patients with mild AD. Furthermore, changes in
VO2peak appear to be associated to changes in cognition and neuropsychiatric symptoms.
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INTRODUCTION
The benefits of physical activity on physical func-
tion and cognitive performance in patients with
Alzheimer’s disease (AD) are receiving increased
attention due to the lack of a disease modifying medi-
cal treatment in AD. Studies have shown that physical
activity has the potential to improve physical func-
tion and helps to maintain activities of daily living in
patients with dementia [1–3]. In addition, both animal
studies and studies in humans suggest that physical
activity may have a role in modifying the disease
process and maintaining cognitive function in AD
[4]. In patients with AD, a link between cardiores-
piratory fitness (determined by peak oxygen uptake,
VO2peak) and cognition has been suggested, and low
VO2peak appears to be associated with brain atrophy
in patients with mild AD [5–7]. However, the associ-
ation between VO2peak and cognition in patients with
AD is still unclear. Based on trials that were highly
heterogeneous in terms of dementia type and sever-
ity, and exercise mode, two meta-analyses concluded
that it is not yet established if physical exercise has a
positive effect on cognitive function in patients with
dementia [1, 8]. A third meta-analysis of 18 RCTs
and 802 patients [8] concluded that physical activity
interventions has a positive overall effect on cognitive
function, and that the effect is driven by interven-
tions that included aerobic exercises independent of
the type of dementia [9].
The multi-center study ADEX (Preserving Cogni-
tion, Quality of Life, Physical Health and Functional
Ability in Alzheimer’s Disease: the Effect of Physical
Exercise) included 200 community-dwelling persons
with mild AD and showed that 16 weeks of moderate-
to-high intensity aerobic exercise had a positive
effect on VO2peak (estimated by the Astrand test)
and neuropsychiatric symptoms (using the 12-item
Neuropsychiatric Inventory, NPI) [10, 11]. While
the primary outcome Symbol Digit Modalities Test
(SDMT), a test of mental speed and attention, did
not improve in the intention-to-treat population, the
per protocol analyses showed that results in SDMT
were preserved in participants with high exercise
attendance and high training intensity compared to
those in the control group [10]. This suggests that
a dose-response relation between aerobic exercise
and cognition may be present. However, in the main
study we were not able to detect whether the effects
on SDMT and NPI were mediated by the exer-
cise intervention itself or other factors including a
generally higher physical activity level, the social
interaction between participants and/or the interac-
tion with health professionals.
Only one of the ADEX-centers had the gold stan-
dard equipment for measuring peak oxygen uptake
(VO2peak), which was the reason why the Astrand
test [12, 13] was chosen to estimate VO2peak in the
main study. This test is relatively inexpensive, simple,
easy to implement, appropriate for assessing change
over time, and can be carried out in persons with
mild-moderate dementia. However, the formula for
calculating VO2peak uses the age predicted maximal
heart rate (HR = 220-age), an estimate which is sub-
ject to some uncertainty [14]. In addition, valid test
results cannot be obtained in persons who use beta-
blockers or other medications that reduce the heart
rate, because either the target HR cannot be achieved
or the VO2peak is overestimated.
In patients with AD, only few studies have
measured VO2peak by direct breath-by-breath car-
diopulmonary exercise test (CPET) [5–7, 15–17],
which is the gold standard for assessing VO2peak.
Furthermore, to our knowledge no studies have
investigated whether exercise can improve VO2peak
measured by CPET in patients with mild AD. Based
on secondary outcome analyses from a subset of the
participants in the ADEX study, the aim of this study
was to investigate 1) the effect of moderate-to-high
intensity aerobic exercise on VO2peak in patients with
mild AD using CPET, and 2) the association between
changes in VO2peak and changes in cognition and
neuropsychiatric symptoms.
MATERIALS AND METHODS
This study included data from a subset of partici-
pants in the large randomized controlled trial ADEX,
a single-blinded multicenter RCT, which involved
8 Danish memory clinics and enrolled 200 partici-
pants from January 2012 to June 2014. Only 3 of the
8 memory clinics had the equipment for advanced
cardiopulmonary exercise testing and expertise in
testing. The 55 participants from these three memory
clinics in the Metropolitan area (Danish Dementia
Research Center, Rigshospitalet; Regional Demen-
tia Research Center, Roskilde Hospital; and Memory
Clinic, Glostrup Hospital) were offered to participate
in the sub-study. 55 of 66 (29 from the intervention
group and 26 from the control group) agreed to partic-
ipate in the sub-study and after the assessments in the
main study they completed a test of maximal oxygen
uptake (VO2peak).
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The study adhered to the Helsinki declaration and
was approved by The Danish National Committee
on Biomedical Research Ethics (H-3-2011-128) and
informed consent was obtained from each participant.
ClinicalTrials.gov no.: NCT01681602.
Participants and study procedures
Inclusion criteria were: a diagnosis of AD accord-
ing to the NINCDS-ADRDA criteria [18]; age 50–90
years; a score of 20 or above on the Mini-Mental State
Examination (MMSE); and having contact more than
once monthly to a caregiver who accepted to take part
in the study. Use of anti-dementia or mood stabilizing
medication was permitted if the doses had been stable
for at least three months preceding the enrolment.
Exclusion criteria were: unstable cardiac disease;
any musculoskeletal problems, joint problems and
neurological diseases that contraindicated aerobic
exercise; participation in moderate to high intensity
exercise twice or more weekly. The complete list of
all inclusion and exclusion criteria has been published
in a protocol paper [19].
Patients who agreed to participate and fulfilled the
inclusion criteria completed the baseline assessments
and were subsequently randomized in groups of 4–10
participants to an intervention group (IG) or a con-
trol group (CG) at each of the contributing memory
clinics. The randomization was done using a com-
puterized random-number generator in favor of the
exercise program if an odd number of participants
were included.
Intervention
The participants in the IG exercised 1 h 3 times
weekly for 16 weeks in groups of 2–5 partici-
pants supervised by an experienced physiotherapist.
In week 1–4, the priority was on strength train-
ing of the lower extremity muscles (twice weekly)
and introduction to aerobic exercise (once weekly).
The following 12 weeks comprised 10 min of warm
up followed by 3 times 10 min of moderate-to-
high intensity aerobic exercise with small breaks of
2–5 min in between. The exercise was conducted
on an ergometer bicycle, cross trainer, or treadmill
and the target intensity was 70–80% of maximal
hearth rate (HR, i.e., 220 minus the person’s age).
The average HR was monitored during the aerobic
exercises (3 × 10 min of exercise plus the pauses,
in total 34–40 min) and documented in a training
logbook. For each participant, the exercise intensity
was estimated as: average HR of all exercise ses-
sions/maximal HR (%). To ensure that the planned
training intensity was reached the Borg Scale of Per-
ceived Exertion was used as a supplement [20]. The
total number of attended exercise sessions/total num-
ber of offered exercise sessions (%) was used to
determine the attendance rate of each participant.
Low adherence did not lead to exclusion.
The participants in the CG received usual care dur-
ing the 16 weeks of the exercise intervention.
Assessments
VO2peak was measured at baseline and after the 16-
week intervention by a specialized physiotherapist
at Bispebjerg Hospital who had extensive expertise
in testing cardiac patients. Cognitive tests and neu-
ropsychiatric scales were administered by raters at
the memory clinics. All assessors were blinded to the
allocation of the participants.
VO2peak
CPET was performed using a graded cycle ergome-
ter (Monarch) with a pedaling frequency of >60
RPM and increment increasing load to exhaustion,
and a completed test in 6–12 min [21]. The test was
performed with a mask for measurement of peak
oxygen uptake by indirect calorimetry and expired
gases were collected online and analyzed with
a metabolic measurement system (Jaeger, Master
Screen CPX vers.5.21, Cardinal Health, Germany).
Maximal effort was determined by the respiratory
exchange ratio (RER), currently the best non-invasive
indicator of exercise effort and a secondary criterion
for having attained maximal oxygen uptake [22].
VO2peak was measured at termination of the test,
caused by either cardiovascular exhaustion or onset
of leg fatigue requiring termination of the test. Vari-
ables selected for this paper are VO2peak (ml/kg/min),
absolute VO2peak (ml/min), RER (ratio) and maximal
HR (beats/min).
CPET was self-terminated by the subjects when
they claimed that they had achieved maximal effort.
However, we considered maximal or nearly maximal
effort to be achieved if the RER was ≥1.05 [23].
Cognitive tests and neuropsychiatric rating
The Symbol Digit Modalities Test (SDMT) [24]:
The primary outcome measure in the ADEX study
was the SDMT, which assesses mental speed and
attention. Participants are asked to decode lines of
symbols for 120 s using a number to symbol key. The
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test score is defined as the number of correct answers.
A higher test score indicates a better performance.
The 12-item Neuropsychiatric Inventory (NPI)
[25]: Based on interviews with caregivers the NPI
assesses symptoms and behavior common in patients
with dementia. This includes hallucinations, agi-
tation, depression, anxiety, apathy, etc., which is
retrospectively assessed for the previous 4 weeks. The
score range is 0–144 with higher ratings indicating
worse symptoms and behavior.
Descriptive variables
Sex, age, comorbidities, general cognitive impair-
ment (MMSE), co-habitation, and physical activity.
Statistical analyses
To assess the differences in baseline characteristics
between the IG and the CG, Fisher’s exact test was
used for categorical data, and Wilcoxon’s signed rank
test for continuous data. The differences in outcome
changes from baseline to the 16-week follow-up
between the two randomization-groups were ana-
lyzed in linear regression models. The method of
generalized estimating equations (GEE) was used to
account for the longitudinal data; indicator variables
were used to adjust for heterogeneity between clinics
and training groups. Data on the outcomes at follow-
up were weighted by the inverse of the probability of
still being in the study; estimated in a logistic regres-
sion model with the patient’s baseline characteristics
and the observed outcome at baseline as covariates.
The associations between changes in SDMT, NPI,
and VO2peak were assessed by Spearman’s rank cor-
relation coefficient, rho. SAS 9.4 was used for all
analyses. The level of significance was p≤ 0.05.
RESULTS
Of the 55 participants enrolled into the sub study,
52 completed the baseline test and 49 completed the
test at follow-up (Fig. 1).
The median age was 69 years (range 52–83),
which is similar to the median age in the whole
ADEX patient group [11]. There were no signifi-
cant between-group differences in any of the baseline
characteristics shown in Table 1.
Exercise attendance rate (mean(SD)) was 85.2%
(16.8%) and exercise intensity 79.6% (10.6%) of
maximal heart rate for participants not using beta-
blockers in the intervention group (n = 24, 92%).
Training was safe with no serious adverse events
related to the exercise intervention [11].
The test of VO2peak was not performed in three of
the 55 included participants due to use of pacemaker
(n = 1), a recently sprained ankle (n = 1), and knee
pain (n = 1). RER of >1.05 was achieved in 37 (76%)
out of 49 participants who completed the baseline and
follow-up tests.
Effect of the 16 weeks exercise intervention on
VO2peak
We found a 13% increase in VO2peak
(2.9 ml/kg/min) in IG following the intervention
period and a retained VO2peak in CG (–0.8 ml/kg/min)
(Table 2). The between-group differences in mean
change from baseline was in favor of the IG following
the intervention period for both VO2peak (p = 0.003)
and absolute VO2peak (p = 0.001) (Table 2). There
was no between-group difference in changes in body
weight (p = 0.446) (Table 2).
Excluding participants with an RER≤1.05 from
the analyses did not change the results (Table 3).
Associations
The relationship between changes over 16 weeks
in VO2peak and the selected measures of cogni-
tion and neuropsychiatric symptoms were examined
for participants with complete data sets. We found
significant positive associations between changes
in VO2peak and NPI (Rho = –0.41, p = 0.042) and
between changes in VO2peak and SDMT (Rho = 0.36,
p = 0.010) (Figs. 2 and 3). Separate analyses of data
from each group showed that there was a positive
association between VO2peak and SDMT (rho = 0.74,
p < 0.0001) in the control group but not in the inter-
vention group (rho = 0.23; p = 0.26); and there was no
correlation between NPI and VO2peak in any of the
groups.
DISCUSSION
To our knowledge, this study is the first random-
ized controlled trial to find a significant effect of an
exercise intervention on VO2peak (ml/kg/min) when
using CPET in patients with mild AD. When pool-
ing data from the IG and the CG our results show
that there is a positive association between changes
in VO2peak and changes in cognitive test results and
ratings of neuropsychiatric symptoms in patients with
mild AD.
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Fig. 1. Flowchart of the sub-group study in ADEX.
VO2peak can be improved by exercise in patients
with mild cognitive impairment (MCI) [26] but the
feasibility of improving VO2peak in patients with AD
has so far not been established. In older healthy
adults VO2peak is related to overall physical func-
tion [27], and in patients with early stage AD a
correlation between VO2peak and physical functional
performance, e.g., 50-foot walk and chair rise, has
been reported [17]. Because high physical capacity
helps maintain activities of daily living in patients
with dementia [1–3], improving VO2peak may have
important implications for decreasing the risk of
dependency in patients with AD. A meta-analysis
[9] suggests that aerobic exercises positively influ-
ence cognitive function in patients with dementia,
and in line with this we found a correlation between
changes in VO2peak and NPI and SDMT, respectively,
when we combined the data from the IG and the CG.
The physiological mechanism behind our findings is
unknown. However, an association between VO2peak,
memory composite score and hippocampal volume in
patients with MCI and AD has been reported [28].
Results from previous studies suggest that it is fea-
sible to measure and detect changes in VO2peak using
CPET in patients with mild AD [7, 16, 28, 29]. Of
the 55 participants, only 2 participants were unable
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Table 1
Baseline characteristics
Intervention Group Control Group p
n (%) 29 (53.7) 26 (47.3)
Sex (male), n (%) 14 (48.3) 17 (65.4) 0.278
Age (y), mean (SD) 69.2 (6.9) 68.9 (7.2) 0.854
Caregiver living with patient, n (%) 23 (79.3) 18 (69.2) 0.537
PASE, median (IQR) 76 (60–121) 97 (55–143) 0.458
Comorbidities
Hypertension, n (%) 13 (44.8) 11 (42.3) 0.850
Diabetes, n (%) 3 (10.3) 2 (7.7) 0.733
Hypercholesterolemia, n (%) 10 (34.5) 8 (30.8) 0.770
Stroke, n (%) 0 (0) 0 (0)
Acute myocardial infarction, n (%) 0 (0) 0 (0)
Medicine
Hypertension medicines, n (%) 13 (44.8) 10 (61.5) 0.785
Depression medicines, n (%) 6 (20.7) 5 (19.2) 0.893
Alzheimer medicines, n (%) 29 (100) 23 (88.5) 0.100
Betablockers, n (%) 2 (6.9) 2 (7.7) 0.910
Cognitive performance
MMSE, mean (SD) 25.1 (2.9) 25.5 (3.3) 0.607
SDMT, mean (SD) 35.0 (12.3) 28.1 (14.6) 0.074
NPI, mean (SD) 7.9 (8.1) 9.2 (10.2) 0.607
Cardiorespiratory fitness, mean (SD)
VO2peak n = 52 (ml/kg/min)* 21.9 (5.9) 25.3 (6.9) 0.068
VO2peak RER≥1.05 (ml/kg/min)* 23.4 (6.0) 26.6 (6.6) 0.134
VO2peak absolute(ml/min)** 1,563 (448) 1,714 (574) 0.297
VO2peak absolute RER≥1.05, (l/min)** 1,636 (449) 1,821 (559) 0.249
Respiratory exchange ratio (RER) 1.17 (0.14) 1.15 (0.14) 0.574
Maximal heart rate (bpm) 137 (24) 140 (24) 0.656
MMSE, Mini-Mental State Examination range from 0 (severe impairment) to 30 (no impairment); SDMT,
Symbol Digit Modalities Test. Number of correct matches in 120 s are reported, with a higher score
indicating a higher level of mental speed and attention; NPI, Neuropsychiatric Inventory range from 0
to 144, with higher scores indicating increased behavioral and psychological symptoms; PASE, Physical
activity scale for the elderly, with higher scores indicating higher levels of habitual physical activity;
VO2peak, Peak oxygen uptake measured by direct breath-by-breath cardiopulmonary exercise test (CPET);
RER, respiratory exchange ratio.
Table 2
Effect of the 16 weeks exercise intervention on VO2peak
Intervention group (n = 29) Control group (n = 23) Between-group differences in
mean change from baseline
Variables Baseline 16-week Baseline 16-week  (95%CI) p
follow-up follow-up
VO2peak (ml/kg/min) 21.9 (5.9) 24.8 (7.4) 25.9 (6.5) 25.1 (5.5) –3.9 (–6.3; –1.5) 0.003
VO2peak (ml/min) 1,563 (448) 1,771 (578) 1,747 (564) 1,635 (610) –330 (–489; –170) 0.001
RER 1.17 (0.14) 1.13 (0.13) 1.16 (0.13) 1.14 (0.13) –0.03 (–0.06; 0.00) 0.087
HRmax (bpm) 137 (24) 136 (25) 142 (21) 142 (24) –3.4 (–11.3; 4.6) 0.402
Body weight (kg) 72.3 (14.9) 72.1 (15.9) 67.3 (12.0) 68.9 (12.5) –0.6 (–2.1; 0.9) 0.446
Baseline and 16-week follow-up with unadjusted mean ± SD and mean outcomes of the Intervention Group compared to mean
outcomes in Control Group, beyond the difference already present at baseline, adjusted for clustering within training groups and
centers, RER: respiratory exchange ratio, HRmax: maximal heart rate.
to perform the CPET due to comorbidities not related
to AD, and only one person was unable to complete
the test due to knee pain. Further, the proportion of
participants with an RER≥1.05 in our study com-
plies with a reliability study (n = 14) finding 71% of
patients with mild AD reaching an RER≥1.05 and
93% reaching an RER>1.0 in a treadmill exercise test
[29]. In that study, an excellent reliability (ICC = 0.92,
CI 0.78–0.97) was reported, when VO2peak was mea-
sured 3 days apart [29]. We chose a cycle ergometer
test because all Danes learn to bike at an early age and
biking for transportation is very common throughout
life. One could also speculate that patients with AD
may feel safer on a cycle ergometer, which is not
as challenging with regards to balance as a tread-
mill, especially for those who have gait impairment,
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Table 3
Effect of the 16 weeks exercise intervention on VO2peak if RER≥1.05
Intervention group, n = 20 Control group, n = 17 Between-group
differences in mean
change from baseline
Variables Baseline 16-week Baseline 16-week  (95%CI) p
follow-up follow-up
VO2peak (ml/kg/min) 23.4 (6.0) 26.0 (7.0) 26.6 (6.6) 25.7 (6.1) –4.2 (–6.7; –1.8) 0.001
VO2peak (ml/min) 1,636 (449) 1,893 (533) 1,821 (559) 1,717 (650) –352 (–609; –94) 0.007
RER 1.22 (0.11) 1.18 (0.08) 1.20 (0.10) 1.20 (0.09) 0.03 (–0.02; 0.08) 0.258
HRmax (bpm) 141 (22) 141 (23) 146 (19) 150 (21) 2.7 (–6.3; 11.5) 0.560
Body weight (kg) 73.6 (15.5) 73.8 (15.8) 68.2 (12.7) 70.5 (10.4) 1.2 (–3.1; 5.5) 0.583
Baseline and 16-week follow-up with unadjusted means ± SD and mean outcomes of the Intervention Group compared to
mean outcomes in Control Group, beyond the difference already present at baseline, adjusted for clustering within training
groups and centers, RER: respiratory exchange ratio, HRmax: maximal heart rate.
Fig. 2. Correlation between changes in VO2peak and changes in
NPI (n = 49), Rho = –0.41, p = 0.042. NPI, Neuropsychiatric Inven-
tory, score range 0–144, with higher scores indicating increased
behavioral and psychological symptoms.
motor coordination complications, and/or are afraid
of falling [30].
A general improvement in neuropsychiatric symp-
toms (NPI) following the exercise intervention was
present in the main study, and SDMT improved
in participants with the highest exercise dose [10].
Our results showed a positive association between
changes in VO2peak and neuropsychiatric symptoms,
which suggests a mutual effect of cognition on neu-
ropsychiatric symptoms, and potentially imply a
positive effect of exercise training upon AD cognitive
capacity and symptoms.
Although the analyses suggest causal effects,
this cannot be ascertained, and furthermore the
analyses cannot detect potential mediating effects.
Also, in our study, the correlation between cogni-
tion/neuropsychiatric symptoms and VO2peak was not
straightforward: when correlations were performed
Fig. 3. Correlation between changes in VO2peak and changes
in SDMT (n = 47), Rho = 0.36, p = 0.010. SDMT, Symbol Digit
Modalities Test are the number of correct matches in 120 s, with a
higher score indicating a higher level of mental speed and attention.
separately on control group and intervention group,
the association was only evident in the control group
for SDMT. There could be numerous explanations for
this unexpected finding, but obviously, the small sam-
ple size makes interpretations difficult. In particular,
we cannot exclude that other factors not accounted for
may have caused changes in symptoms and fitness in
both groups. However, the association is noteworthy
and calls for more research into the area.
The link between VO2peak and symptomatology of
AD may in theory be mediated through effects on
the pathophysiology associated with AD [4]. Cross-
sectional studies have found an association between
VO2peak and brain atrophy in AD [5, 6], and in a
longitudinal study VO2peak was associated with pro-
gression of dementia severity and brain atrophy over
2 years in patients with AD [7]. These results sug-
gest that high VO2peak may have an impact on the
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rate of neurodegeneration. A direct effect on specific
AD pathology (amyloid- and tau accumulation) is
still uncertain [31], although an exercise program
similar to ours documented a reduction in tau in
cerebrospinal fluid as a result of exercise in older
adults with MCI [32]. Multiple other mechanisms
that could be induced in the relatively short time inter-
val of 4 months may more likely be involved. These
include improved cerebrovascular and endothelial
function, reduction in oxidative stress and neuroin-
flammation, and improved metabolic function, which
may contribute to improved neuronal function [4, 33,
34]. In healthy persons using resting-state functional
magnetic resonance imaging, exercise increased the
functional connectivity of neural networks [35], but
this mechanism has not yet been established in AD.
In addition, studies have found exercise associated
increases in levels of brain-derived neurothropic fac-
tor (BDNF) and insulin-like growth factor 1 (IGF-1)
to be important factors behind the possible protective
mechanism of physical activity [4, 36], but evidence
for these pathways is scarce in AD [31].
In the main effect study (n = 200), we did not find
any significant association between changes in esti-
mated VO2peak and changes in results in cognitive
tests and in neuropsychiatric ratings [11]. One of
the reasons for this discrepancy in results could be
the aforementioned problem with the Astrand test, a
method that is less valid than direct breath-by-breath
CPET measurement [12–14].
The strength of our study includes a meticulous
design including highly supervised moderate to high
aerobic exercise with a high adherence rate and
the use of the gold standard CPET measurement of
VO2peak in a well characterized group of community-
dwelling patients with mild AD. A weakness of the
study is that the control group was not offered any
social activity. It cannot be excluded that the social
interaction in the training group may have had a pos-
itive impact on changes in NPI, and that the social
interaction in the training group may have contributed
to the high adherence rate and thus to the improve-
ment in fitness. Finally, our sample is fairly small
and our participants were physically well-functioning
[37], which may limit the generalizability of our find-
ings to all patients with mild AD.
Conclusion
Our study shows that it is possible to improve
cardiorespiratory fitness in community-dwelling
patients with mild AD. Moreover, the results suggest
that this improvement may have a positive effect on
mental speed, attention and neuropsychiatric symp-
toms in patients with mild AD. However, studies
are needed to confirm the findings from our study
and determine, which mechanisms that may explain
potential causal relations between cardiorespiratory
fitness and cognition and neuropsychiatric symp-
toms, respectively.
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